This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Sarepta Therapeutics, Inc.
Drug Names(s): Oncomyc-NG
Description: Oncomyc-NG is a third-generation antisense NEU-GENE compound targeting c-myc and is a nearly identical NEUGENE to Resten-NG.
Additional information available to subscribers only: